Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1065 | 998 | 1147 | 1266 | 1572 | 2775 |
Fund Return | 6.52% | -0.25% | 14.74% | 8.19% | 9.47% | 10.75% |
Place in category | 262 | 368 | 320 | 64 | 74 | 33 |
% in Category | 45 | 59 | 50 | 12 | 12 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Index World Fund A Acc | 9.15M | 12.38 | 8.78 | 12.07 | ||
Fidelity Index World Fund P Accumul | 6.96B | 12.53 | 8.97 | 12.26 | ||
Fidelity Index US Fund Class A Acc | 3.8M | 14.72 | 10.80 | 14.75 | ||
Fidelity Index US Fund P Accumulati | 4.13B | 14.93 | 11.05 | 15.02 | ||
Fidelity European Fund W Income | 115.52M | 6.53 | 8.20 | 10.74 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
iShares Continental Europe Eq D Acc | 6.32B | 6.88 | 6.24 | 8.78 | ||
GB00BJL5BS14 | 6.32B | 6.88 | 6.24 | 8.79 | ||
Continental European Flexible Fundg | 20.36M | 8.16 | 3.09 | 12.88 | ||
GB00B80QGH28 | 4.39B | 6.85 | 6.08 | 8.82 | ||
European Dynamic Fund A Accumulatio | 4.48B | 6.84 | 1.39 | 11.20 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.10 | 752.6 | -2.12% | |
ASML Holding | NL0010273215 | 6.07 | 618.20 | -1.42% | |
Nestle | CH0038863350 | 5.17 | 82.20 | -0.63% | |
SAP | DE0007164600 | 4.71 | 213.800 | -1.36% | |
Roche Holding Participation | CH0012032048 | 4.62 | 272.30 | -0.29% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review